ClinicalTrials.gg
CompletedNCT07498530AGE-BOTUpdated Nov 10, 2026

Virtual Assistant for Exercise Adherence in Older ADULTS

An interventional study of Exercise program in Older Adult, Exercise and Adherence, sponsored by University of Valencia. Completed at 1 site in Spain. Open to participants aged 59 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-10.

Sponsored by University of Valencia · Not applicable, Interventional, and Other

How we know

Updated Nov 10, 2026Now CompletedStart date moved+3 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
78
Allocation
Non-randomized
Ages
59 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 25 studies in Motor Activity by University of Valencia — 14 open to participants now, 15 under way, none of them phase 3. Motor Activity · University of Valencia.

Enrollment
8th of 22
78 · median 61
Started
2026
with 7 others
No phase
22 of 25
11 open now
Registered
22nd of 25
by date

Among the 25 studies in Motor Activity by University of Valencia, this one is the 8th largest by enrollment of the 22 interventional ones that give a count, is one of 8 that started in 2026, is one of 22 with no phase, and was the 22nd registered.

Motor Activity

9,827 studies on the registry are indexed under Motor Activity; 1,911 are open to participants now.

Browse Motor Activity studies →

Open to participants now

14 of the 25 studies in Motor Activity by University of Valencia are open now, in 1 country. Recruiting first, the newest first:

9 more — sign in →

By country, each count listing its studies:

All 14 open studies →

Where they have run

Who these studies take

Of the 1,207 Motor Activity studies recruiting now, 524 (43%) set no upper age limit and 538 (45%) stop at 75 or younger; 180 take children under 18; 420 take healthy volunteers.

This study: 59 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 25 studies in Motor Activity by University of Valencia, or all of them as a file.
02

Study summary

This study will evaluate the effectiveness of a virtual assistant-guided exercise program to improve adherence in older adults. In a nonrandomized controlled clinical trial, the experimental group will complete a 12-week, home-based program (60-minute sessions, 3 times per week) supported by a virtual assistant (BOT). The control group will comprise community-dwelling older adults already engaged in the municipal program Enguera se saludable, which delivers an in-person exercise program of comparable frequency and duration. The primary outcome is exercise adherence, defined as the proportion of prescribed sessions completed. Secondary outcomes include muscle strength, balance, functional capacity, health-related quality of life, and the user experience and usability of the virtual assistant.

Read the detailed description

The objective of this study is to determine whether a virtual assistant-controlled, home-based exercise program can improve adherence to therapeutic exercise among older adults, compared with a conventional municipal program of similar dosage. Although exercise is effective for preserving function and quality of life during aging, adherence remains suboptimal. Virtual assistants may offer a scalable and acceptable solution to support sustained participation.

The study will employ a nonrandomized controlled clinical trial (quasi-experimental design) involving community-dwelling adults aged ≥60 years. Participants will be allocated to groups based on program pathway:

Experimental group (Virtual Assistant/BOT): a structured home-based exercise program (60 minutes per session, 3 sessions per week for 12 weeks), guided and monitored by a virtual assistant (BOT), including automated session delivery, reminders, and adherence tracking.

Control group (Municipal program): older adults already participating in Enguera se saludable, an onsite, instructor-led municipal program with equivalent frequency and duration (60 minutes, 3 times per week for 12 weeks). Attendance records from the municipal program will quantify adherence.

The primary outcome is exercise adherence, defined as the proportion of prescribed sessions completed during the 12-week period, with predefined adherence thresholds (e.g., ≥75% of sessions completed). Secondary outcomes include changes in muscle strength, balance, functional performance, and health-related quality of life. Additional measures will include user perceptions, usability, and satisfaction with the virtual assistant to evaluate acceptability and feasibility.

Given the nonrandomized design and the pre-existing enrollment of the control group, the study will incorporate the following methodological safeguards:

Baseline demographic and clinical characteristics (e.g., age, sex, comorbidities, prior activity level) will be comprehensively documented.

Baseline imbalances will be controlled through statistical adjustment (e.g., covariate adjustment, propensity score procedures, and sensitivity analyses) to reduce selection bias and confounding.

Exercise dosage (frequency, duration, and intervention length) will be matched across groups, or, when small discrepancies arise, dosage will be included as a covariate in the analyses.

This study is expected to contribute evidence regarding whether a virtual assistant-based exercise program represents a viable, effective, and acceptable alternative to conventional program delivery models for promoting active and healthy aging in community-dwelling older adults.

03

Conditions studied

  • Older Adult
  • Exercise
  • Adherence
  • Prevention
  • New Technologies

Browse trials for

04

Who can participate

Ages eligible
59 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults aged 60 years or older.
  • Community-dwelling individuals capable of participating in an exercise program.
  • Ability to complete 60-minute exercise sessions, three times per week during the 12-week intervention.
  • Experimental group (BOT Group): Participants willing to use a smartphone/tablet and interact with the virtual assistant.
  • Control group (Municipal Exercise Group): Individuals already enrolled in the municipal program Enguera se saludable.
  • Ability to understand the study procedures and provide written

Exclusion criteria

Exclusion Criteria:

  • Medical to physical exercise, as determined by clinical judgment (e.g., uncontrolled cardiovascular, respiratory, or metabolic conditions).
  • Severe cognitive impairment or neurological conditions that limit the ability to follow instructions or safely perform the exercise program.
  • Severe mobility limitations preventing participation in structured exercise (e.g., inability to walk independently with or without aid).
  • Acute musculoskeletal injuries or recent surgeries that contraindicate exercise participation.
  • Individuals currently participating in another structured exercise program that would interfere with the study interventions (other than Enguera se saludable for the control group).
  • Inability or unwillingness to comply with the requirements of the study (frequency, duration, assessments).
  • For the BOT group: lack of access to a device compatible with the virtual assistant or inability/unwillingness to use it.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
78 participants (actual)

Study arms

  • Experimental
    Bot Group

    Participants in this group will complete a 12-week home-based exercise program delivered and monitored by a virtual assistant (BOT). The program consists of 60-minute sessions, three times per week, including guided instructions, automated reminders, and adherence tracking. The BOT provides real-time session support and records participation throughout the intervention.

    Procedure: Exercise program

  • Active comparator
    Enguera program Group

    Participants in this group are individuals already enrolled in the municipal program "Enguera se saludable", which offers a face-to-face, instructor-led exercise program of the same duration and frequency (60 minutes, three times per week for 12 weeks). Attendance is recorded routinely by program instructors and will be used to assess adherence.

    Procedure: Exercise program

Interventions

  • ProcedureExercise program

    BOT Group: Home-based exercise program delivered through a virtual assistant for 12 weeks (60 minutes, three times per week), including guided instructions and adherence monitoring. Enguera Exercise Group: Face-to-face, instructor-led exercise sessions from the Enguera se saludable program, with the same frequency and duration (60 minutes, three times per week for 12 weeks).

06

What researchers measure

Primary outcomes

  1. Exercise Adherence (% of prescribed sessions completed)

    Exercise adherence will be defined as the percentage of prescribed exercise sessions completed during the 12-week intervention. A single adherence value will be calculated for each participant as: \\text{Adherence (%) = (Sessions completed / Sessions prescribed) × 100} Measurement method: Virtual Assistant/BOT Group: Adherence will be recorded automatically by the virtual assistant (BOT), which logs session completion in real time. Municipal Exercise Group: Adherence will be calculated from attendance records routinely collected in the Enguera se saludable municipal program, using the same formula (completed / prescribed × 100). Although adherence is obtained from different data sources, the measurement itself is identical in both groups, expressed as a percentage (%).

    Time frame: End of the 12-week intervention.

Secondary outcomes

  1. Physical performance assessed by the Short Physical Performance Battery (SPPB)

    Lower-limb functional performance will be assessed using the Short Physical Performance Battery (SPPB), a validated instrument for older adults. The SPPB includes three components: balance tests, gait speed, and the 5-times sit-to-stand test. Each component is scored from 0 to 4, yielding a total score from 0 to 12, with higher scores indicating better physical performance. Unit of measurement: SPPB total score (0-12 points).

    Time frame: Baseline and 12 weeks.

  2. Accelerometry-Based Physical Activity (Moderate-to-Vigorous Activity Levels)

    Moderate-to-vigorous physical activity (MVPA) will be quantified using a wrist- or hip-worn triaxial accelerometer. MVPA will be calculated according to established cut-points for older adults, expressed as minutes per day accumulated at moderate or vigorous intensity. Devices will be worn during the monitoring period, and raw acceleration data will be processed using standardized algorithms to derive daily MVPA time. A single MVPA value will be generated for each assessment period. Unit of measurement: Minutes/day of MVPA (moderate-to-vigorous physical activity).

    Time frame: Baseline and 12 weeks

  3. Risk of falls measured by the FallSkip® system (Fall Risk Index, 0-100)

    Risk of falls will be assessed using the FallSkip® system, an instrumented device that evaluates fall risk in older adults through a standardized functional protocol. The device records parameters such as reaction time, postural stability, gait acceleration/deceleration patterns, and sit-to-stand performance. These variables are integrated automatically by the device software to generate a Fall Risk Index on a 0-100 scale, with higher values indicating greater risk of falls. A single Fall Risk Index score will be obtained for each participant at every assessment time point. Unit of measurement: FallSkip® Fall Risk Index (0-100 points).

    Time frame: Baseline and 12 weeks

  4. User experience and usability of the virtual assistant measured with a Visual Analog Scale (VAS)

    User experience and usability of the virtual assistant (BOT) will be evaluated using a Visual Analog Scale (VAS), an anchored numerical scale ranging from 0 to 10, in which 0 represents the worst possible user experience/usability and 10 represents the best possible user experience/usability. Participants will rate their overall experience and perceived usability of the virtual assistant on this single-item scale. A single VAS score will be obtained for each assessment period. Unit of measurement: Score on the Visual Analog Scale (0-10), where higher scores indicate better user experience/usability.

    Time frame: 12 weeks.

07

Study locations

1 site
  • Carmen García Gomariz
    Valencia, 46010, Spain
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Apr 2026 to primary completion in Nov 2026, 7 months.

Of 5,176 non-industry interventional studies with no phase under Motor Activity, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 36. This study's 7 months is below that.

Counting every sponsor, half of 5,236 studies reached it within 17 months; a quarter within 7 and three quarters within 36.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 10, 2026: start Feb 2026 → Apr 2026, primary completion Dec 2026 → Nov 2026 and completion Dec 2026 → Nov 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Mar 20, 2026
First posted
Mar 27, 2026
StartActual
Apr 4, 2026was Feb 2026
Primary completionActual
Nov 8, 2026was Dec 2026
CompletionActual
Nov 9, 2026was Dec 2026
Last update
Nov 10, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Recruiting→Completed
changed Nov 10, 2026
Start date
Feb 1, 2026→Apr 4, 2026
Nov 10, 2026
Primary completion
Dec 30, 2026→Nov 8, 2026 (actual)
Nov 10, 2026
Study completion
Dec 31, 2026→Nov 9, 2026 (actual)
Nov 10, 2026
Enrollment
70 (estimated)→78 (actual)
Nov 10, 2026
Show all 1 update
  1. Nov 10, 2026
    Recruiting→Completed
    Start date Feb 1, 2026→Apr 4, 2026
    Primary completion Dec 30, 2026→Nov 8, 2026 (now actual)
    Study completion Dec 31, 2026→Nov 9, 2026 (now actual)
    Enrollment 70 (estimated)→78 (actual)
    + 3 other changes: verification date, contact details and site details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07498530
Collaborators
Generalitat Valenciana
Responsible party
CARMEN GARCÍA GOMARIZ (principal investigator, University of Valencia) — Principal investigator
First posted
Mar 27, 2026
Start date
Apr 4, 2026
Primary completion
Nov 8, 2026
Completion
Nov 9, 2026
Last update
Nov 10, 2026

Study contacts

CARMEN GARCÍA GOMARIZ, Phd
principal investigator · UNIVERSITAT DE VALÉNCIA DEPARTAMENTO D'INFERMERIA

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion